Log in to save to my catalogue

S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immu...

S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2886466892

S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immunity and identification of immune correlates of protection

About this item

Full title

S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immunity and identification of immune correlates of protection

Publisher

London: BMJ Publishing Group Ltd and British Thoracic Society

Journal title

Thorax, 2023-11, Vol.78 (Suppl 4), p.A78-A79

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd and British Thoracic Society

More information

Scope and Contents

Contents

IntroductionControlled human infection models (CHIMs) involve the deliberate exposure of individuals to a pathogen in a controlled environment. Respiratory organism CHIMs have been utilised to further understanding on the kinetics of infection or host-pathogen immunobiology plus enabling expedited testing of vaccines and therapeutics. A SARS-CoV-2...

Alternative Titles

Full title

S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immunity and identification of immune correlates of protection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2886466892

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2886466892

Other Identifiers

ISSN

0040-6376

E-ISSN

1468-3296

DOI

10.1136/thorax-2023-BTSabstracts.115

How to access this item